-
Research Linking TCE to Parkinson’s Disease Spurs Calls for Ban
May 17, 2023
… Update as of December 9, 2024: In a long-sought victory for the Parkinson’s community, the U.S. Environmental Protection Agency (EPA) … trichloroethylene (TCE). Learn more about the TCE ban and how you can help us make a final push for the EPA to ban …
-
Testing Effects of Improved Levodopa Delivery with Dexterity and Gait Objective Measures
… Objective/Rationale: The objective of this project is to develop an extended-release capsule of levodopa/carbidopa … that will result in constant blood levels of levodopa compared to current extended release therapy while reducing … and the UPDRS Part III scores as well as mobility scores; however, no apparent relationship was observed between …
-
What's Alternative? What to Know about Complementary Medicine for Parkinson's
March 16, 2017
… Page Cancel Register for Webinar What's Alternative? What to Know about Complementary Medicine for Parkinson's First Name Last … is known about natural dietary supplements in PD. Explain how diet can impact Parkinson's disease. Describe why …
-
PPMI Dispatch: More Sites Recruiting While Scientists Uncover New Ways to Predict Parkinson’s
March 25, 2021
… Markers Initiative (PPMI) began enrolling more volunteers into this landmark study. By gathering data from people with … time, PPMI is changing what we know about the disease and how research is done. With a goal to enroll 3,000 new … Greece, Israel, Spain and the United Kingdom. Over the coming months 23 more sites in these and seven other …
-
Testing Whether Alpha-Synuclein is Modified by 4-hydroxy-2-nonenal in the Human Brain
… of 4-hydroxy-2-nonenal Modification on Alpha-synuclein Toxicity Promising Outcomes of Original Grant: The major goal of our grant application was to test whether a protein known as alpha-synuclein becomes … Washington …
-
De-Risking Strategy Leads to Significant Investment in Parkinson's Drug Development
November 6, 2013
… projects jumpstarted by MJFF funding have secured financial commitments to continue their work. “This is why our Foundation exists,” … in check. Further development of drugs that target GCase is an important step toward a cure for PD. Biogen …